Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
23-valent pneumococcal vaccine in military trainees
NCT02079701Phase 4Completed
- Sponsor
- Naval Health Research Center
- Start
- Oct 2000
- Primary completion
- Jun 2003
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 23-valent pneumococcal polysaccharide vaccine in pneumonia, sponsored by Naval Health Research Center. Started Oct 2000; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumonia
Beyond the preview
Go deeper on NCT02079701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02079701.